Equatorial Guinea vs Jordan: Average cost of tuberculosis treatment by type
Equatorial Guinea
20 constant 2022 US$
in 2023
Jordan
20 constant 2022 US$
in 2024
Equatorial Guinea rank
26th
Jordan rank
26th
Average cost of tuberculosis treatment by type over time
- Equatorial Guinea
- Jordan
How they compare
Equatorial Guinea currently reports 20 constant 2022 US$ against 20 constant 2022 US$ in Jordan, a difference of 0 constant 2022 US$.
Across all 5 years both countries report, Jordan has been ahead every year.
Equatorial Guinea ranks 26th and Jordan ranks 26th of 62 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 20 constant 2022 US$ | 20,000 constant 2022 US$ | 19,980 constant 2022 US$ | Jordan |
| 2020s | 19.5 constant 2022 US$ | 77.5 constant 2022 US$ | 58 constant 2022 US$ | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of tuberculosis treatment by type, Equatorial Guinea or Jordan?
- Equatorial Guinea, at 20 constant 2022 US$ against 20 constant 2022 US$ in Jordan as of 2023.
- What is the difference in average cost of tuberculosis treatment by type between Equatorial Guinea and Jordan?
- 0 constant 2022 US$, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Jordan?
- 5 years are reported by both, from 2019 to 2023.
- How do Equatorial Guinea and Jordan rank globally for average cost of tuberculosis treatment by type?
- Equatorial Guinea ranks 26th and Jordan ranks 26th of 62 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of tuberculosis treatment by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per person starting tuberculosis preventive treatment, excluding buffer stock.